Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines
Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines
复制标题
DOI：
10.1016/j.gofs.2018.10.013
复制
发表时间：
2018-12-01
影响因子：
0.8
通讯作者：
Scheffler, M.
中科院分区：
文献类型：
--
作者：
Amat, L.;Bulach, A.;Scheffler, M.
激素和宫内避孕方法为妇女提供了高效的保护，防止意外怀孕。其他的非避孕效果现在已经有了很好的记录。通过口服、透皮和阴道途径使用复合激素避孕药，可以减少月经过多、痛经、功能性卵巢囊肿、良性乳腺和子宫疾病、子宫内膜异位症相关疼痛和复发。卵巢癌风险的降低，包括BRCA综合征、子宫内膜癌和结肠癌的女性。这种影响在避孕停止后会持续数年。仅孕激素避孕药的非避孕益处较少记录。左炔诺孕酮宫内节育器的使用与月经过多、痛经（包括子宫内膜异位症）的减少有关。铜宫内节育器的使用与宫颈癌和子宫内膜癌风险的降低有关。(C)2018年由Elsevier Masson SAS出版。
Hormonal and intrauterine contraceptive methods provide women with highly efficient protection against undesired pregnancy. Additional non-contraceptive effects are now well documented. Combined hormonal contraceptives use, either through the oral transdermal and vaginal route, allow a reduction in menorrhagia, dysmenorrhea, functional ovarian cysts, benign breast and uterine disease, endometriosis-related pain and recurrence. A reduction in ovarian cancer risks, including in women with BRCA syndrome, endometrial and colon cancer is documented. This effect is prolonged for years after contraception discontinuation. Non-contraceptive benefits of progestin-only contraceptives are less documented. Use of the levonorgestrel IUD is associated with a reduction in menorrhagia, dysmenorrhea including in case of endometriosis. Copper IUD use is associated with a decrease in cervix and endometrial cancer risk. (C) 2018 Published by Elsevier Masson SAS.